Skip to main content
SpringerLink
Log in

Thalidomide warning issued for arterial thromboembolism

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Celgene.Direct Healthcare Professional Communication on the association between Thalidomide CelgeneTM (thalidomide) and thromboembolism. Internet Document: [3 pages], 6 May 2011. Available from: URL: http://www.mhra.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thalidomide warning issued for arterial thromboembolism. React. Wkly. 1355, 2 (2011). https://doi.org/10.2165/00128415-201113550-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113550-00003

Keywords

Search

Navigation